EMC
68
-3
BMY
33
-2
FLS
69
2
DHR
39
-2
HOG
29
-2
IFF
53
-3
EFX
38
-2
XYL
39
-2
EBAY
50
-2
SO
59
-5
EA
44
5
NWSA
60
6
VNO
65
-3
GWW
62
-2
BBY
38
-2
KO
38
2
BXP
60
-2
RIG
38
-3
CRM
62
3
PEG
46
-7
EMC
68
-3
BMY
33
-2
FLS
69
2
DHR
39
-2
HOG
29
-2
IFF
53
-3
EFX
38
-2
XYL
39
-2
EBAY
50
-2
SO
59
-5
EA
44
5
NWSA
60
6
VNO
65
-3
GWW
62
-2
BBY
38
-2
KO
38
2
BXP
60
-2
RIG
38
-3
CRM
62
3
PEG
46
-7
Financhill
Back

Kymera Therapeutics Stock Predictions

Gold Set to Skyrocket as Fed Slashes Rates

Click here for the details on this incredible opportunity.
Buy
67

KYMR
Kymera Therapeutics

Last Price:
48.00
Seasonality Move:
69.6%

7 Day Trial

ALL ACCESS PASS

$ 7

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.

Kymera Therapeutics Stock Forecast

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 59.4% based on the past 4 years of stock performance.
  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Kymera Therapeutics Stock Undervalued?
    The current Kymera Therapeutics [KYMR] share price is $48.49. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Kymera Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Kymera Therapeutics has on average historically risen by 59.4% based on the past 4 years of stock performance.

Kymera Therapeutics Stock Rating

Buy
67
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics overpriced?

  • Kymera Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Kymera Therapeutics Stock Price History

Is KYMR stock going to rise?

  • The current trend is moderately bullish and KYMR is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kymeratx.com

52-Week Data

52-Week High:
53.27
52-Week Low:
9.60

Prediction Charts

Market Cap:
2.99B
Price in USD:
48.49
Volume:
355.89K
Beta:
2.19

Technical Analysis

SMA50:
47.00
SMA100:
42.61
SMA200:
39.47
52-Wk Change:
342.02%

Stock Predictions

  • Is Kymera Therapeutics stock public?
    Yes, Kymera Therapeutics is a publicly traded company.
  • What is the Kymera Therapeutics stock quote today?
    The Kymera Therapeutics stock price is 48.49 USD today.
  • How to buy Kymera Therapeutics stock online?
    You can buy Kymera Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-9 43.25 43.34 43.44 42.00
Oct-10 42.61 43.21 43.93 42.36
Oct-11 43.18 45.02 45.29 43.18
Oct-14 44.74 46.05 46.50 44.74
Oct-15 46.43 44.80 46.43 44.35
Oct-16 45.10 49.02 49.17 44.66
Oct-18 46.58 46.41 46.98 45.71
Oct-21 46.23 46.56 46.89 45.54
Oct-22 46.48 48.37 48.58 45.75
Oct-23 48.25 48.76 49.33 47.50
Oct-24 48.95 48.73 49.79 48.37
Oct-25 49.03 47.99 49.53 47.07
Oct-28 49.01 49.08 50.29 48.84
Oct-29 48.53 48.49 49.16 47.75

Kymera Therapeutics Earnings

Kymera Therapeutics Earnings Report: Per Share Kymera Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Kymera Therapeutics Forecast Revenue Growth

Kymera Therapeutics Stock Analysis: Historical quarterly revenues per share for Kymera Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

* Kymera Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.